UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Sheets Smith Wealth Management
Sheets Smith Wealth Management lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 4th quarter, Holdings Channel.com reports. The firm owned 8,019 shares of the healthcare conglomerate’s stock after purchasing an additional 197 shares during the period. Sheets Smith Wealth Management’s holdings in UnitedHealth Group were worth $2,812,000 at the end of the most recent reporting period.
Several other large investors also recently bought and sold shares of the stock. Two Sigma Advisers LP increased its stake in UnitedHealth Group by 195.8% during the second quarter. Two Sigma Advisers LP now owns 760,600 shares of the healthcare conglomerate’s stock worth $224,339,000 after acquiring an additional 503,500 shares during the last quarter. Findlay Park Partners LLP increased its stake in UnitedHealth Group by 69.0% during the third quarter. Findlay Park Partners LLP now owns 1,225,000 shares of the healthcare conglomerate’s stock worth $381,918,000 after acquiring an additional 500,000 shares during the last quarter. Morgan Stanley increased its stake in UnitedHealth Group by 4.9% during the third quarter. Morgan Stanley now owns 7,003,292 shares of the healthcare conglomerate’s stock worth $2,183,416,000 after acquiring an additional 325,936 shares during the last quarter. CIBC Private Wealth Group LLC increased its stake in UnitedHealth Group by 25.5% during the third quarter. CIBC Private Wealth Group LLC now owns 1,579,134 shares of the healthcare conglomerate’s stock worth $492,232,000 after acquiring an additional 321,008 shares during the last quarter. Finally, Nuveen Asset Management LLC increased its stake in UnitedHealth Group by 4.4% during the second quarter. Nuveen Asset Management LLC now owns 7,294,171 shares of the healthcare conglomerate’s stock worth $2,151,416,000 after acquiring an additional 305,797 shares during the last quarter. 86.39% of the stock is owned by hedge funds and other institutional investors.
UNH has been the subject of several recent analyst reports. Mizuho raised their target price on UnitedHealth Group from $361.00 to $380.00 and gave the stock a “buy” rating in a research note on Monday, November 9th. Oppenheimer raised their price target on UnitedHealth Group from $353.00 to $375.00 and gave the stock an “outperform” rating in a research report on Thursday, October 15th. Argus lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, October 19th. Truist raised their price target on UnitedHealth Group from $400.00 to $420.00 in a research report on Tuesday, January 5th. Finally, BMO Capital Markets raised their price target on UnitedHealth Group from $385.00 to $395.00 and gave the stock a “market perform” rating in a research report on Wednesday, December 2nd. They noted that the move was a valuation call. Seven equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $383.50.
NYSE:UNH traded down $2.33 during midday trading on Wednesday, reaching $355.04. The company had a trading volume of 1,972,017 shares, compared to its average volume of 3,410,015. The firm has a market capitalization of $336.87 billion, a price-to-earnings ratio of 20.53, a PEG ratio of 1.53 and a beta of 0.68. The stock’s fifty day simple moving average is $344.91 and its 200-day simple moving average is $322.55. UnitedHealth Group Incorporated has a 12-month low of $187.72 and a 12-month high of $367.95. The company has a current ratio of 0.82, a quick ratio of 0.84 and a debt-to-equity ratio of 0.59.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.98 by $0.53. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The business had revenue of $65.12 billion during the quarter, compared to analysts’ expectations of $63.97 billion. During the same period in the prior year, the firm posted $3.88 EPS. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 16.78 EPS for the current year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 15th. Investors of record on Monday, December 7th were paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.41%. The ex-dividend date was Friday, December 4th. UnitedHealth Group’s payout ratio is 33.09%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
See Also: Is a Roth IRA right for you?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.